Omics-Based Clinical Trials Market to Surpass USD 61.98 Billion by 2032 Driven by Precision Medicine and Multi-Omics Integration – SNS Insider
Expanding applications of genomics, proteomics, transcriptomics, and metabolomics accelerate clinical development, with North America leading and Asia Pacific emerging as…